Search for: "Eli Lilly & Co." Results 41 - 60 of 1,011
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2022, 6:40 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
11 Dec 2021, 8:25 pm by Patent Docs
Patent and Trademark Office; Mark Stewart of Eli Lilly and Co.; and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss the best practices and emerging trends from pre-institution through final hearing, including strategies focused on petition drafting, preliminary patent owner responses, discretionary denial considerations,... [read post]
12 Sep 2021, 10:37 am by Nassiri Law
Eli Lilly and Co say they were qualified and did well in their interviews, but were ultimately passed over for sales positions by younger, less qualified workers. [read post]
18 Aug 2021, 9:31 pm by Patent Docs
Noonan -- The Federal Circuit issued three decisions on Monday relating to Eli Lilly & Co's. challenge in separate inter partes review proceedings on obviousness grounds of nine patents licensed by Teva Pharmaceuticals Int'l, with disparate results. [read post]
23 Mar 2021, 1:35 pm by Tom Lamb
Specifically, besides Xeljanz there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]